Pre-print publication COVID19

PRE-PRINT COVID19: Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19 Authors: Douglas...

BIOASTER & GENCOVERY

BIOASTER first shareholder with its two co-founders Adama OUATTARA and Wassim ABOU-JAOUDE of Gencovery. Wishing success to the first BIOASTER start-up. Gencovery provides cutting-edge software based on digital organisms for...

Discover our new @BIOASTER publication in Poultry Sciences

Discover our new @BIOASTER publication in @PoultrySci We are really happy to share our new publication in @PoultrySci. This #Multiomics study, combining #Metabolomics and #Transcriptomics, aims at deciphering the pathways...

BIOASTER is proud to share a new article published in PLOS ONE.

“Caecal microbiota compositions from 7-day-old chicks reared in high-performance and low-performance industrial farms and systematic culturomics to select strains with anti-Campylobacter activity”. See the article This work carried out in...

Discover our new @BIOASTER publication in @NatureProtocols.

A droplet #microfluidics technology has been developed to measure #proteinsecretion kinetics from #singlecells. This technology has been successfully used to characterize monocyte anergy in septic shock patients. SharedIt link   
Post archive